AGENDA SWISS NORDIC BIO 2022

23 MARCH

TIMEPRELIMINARY PROGRAM
07:45 - 08:10
REGISTRATION & COFFEE
08:10 - 08:25
WELCOME ADDRESS
  • Christoffer Bengtsson, Business Sweden
  • Philipp Jordi, Advisor for Commercial and Economic Affairs, Embassy of Finland in Berne
  • Dr. Thierry Calame, Member of the Board of Directors, Innosuisse – Swiss Innovation Agency
  • Jonas Ribbelöv, Managing Partner, Vator Securities
08:25 - 09:05
FIRESIDE CHAT
  • Per Falk, President, Ferring Pharmaceuticals
  • Dr. Michiel Bröker, Healthcare EMEA, Investment Banking at UBS AG
09:05 - 9:30
NASDAQ & BAKER MCKENZIE IPO WORKSHOP

Moderator: Dr. Michiel Bröker, Healthcare EMEA, Investment Banking at UBS AG

  • Adam Kostyál, Senior VP Head of Listings - EMEA, Nasdaq
  • Joakim Falkner, Head of Capital Markets - Europe, Middle East & Africa, Baker McKenzie
  • Felicia Rittemar, Partner & Head of Life Science - Corporate Finance, Vator Securities
  • Andreas Öhrnberg, CFO, Implantica
09:30 - 09:40
EUREKA / Eurostars presentation
  • Janique Siffert, Programme Manager, Innosuisse - Swiss Innovation Agency
09:40 - 09:55
COFFEE BREAK & NETWORKING
09:55 - 13:00
13:00 - 14:10
NETWORKING LUNCH
14:10 - 18:10
ONE-TO-ONE MATCHMAKING MEETINGS

Face-to-face meetings in Zürich

MAIN SPONSOR

IMPORTANT DEADLINES

20 March 2022
End of registration


21 Feb. to 21 March 2022
Booking of 1-to-1 meetings


23 March 2022
Event date

Simple Social Media Stream: There is no feed data to display!